Alcohol-induced impaired insulin secretion in a Japanese population: 5-year follow up in the Gifu Diabetes Study.


Journal

Journal of diabetes investigation
ISSN: 2040-1124
Titre abrégé: J Diabetes Investig
Pays: Japan
ID NLM: 101520702

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 24 11 2019
revised: 13 03 2020
accepted: 16 03 2020
pubmed: 1 4 2020
medline: 15 9 2021
entrez: 1 4 2020
Statut: ppublish

Résumé

Although moderate alcohol consumption lowers the risk of type 2 diabetes in European populations, the same cannot be assumed for Japanese patients with diabetes related to low insulin secretion rather than resistance. We aimed to evaluate the effects of daily alcohol consumption on glucose tolerance and diabetes development risk in Japanese populations. This retrospective study randomly enrolled 452 men and 659 women aged 40-78 years in 2005 (Gifu, Japan). The participants completed a 75-g oral glucose tolerance test and medical questionnaire. The homeostasis model assessment of insulin resistance, homeostasis model assessment of β-cell function and insulinogenic index were used to estimate insulin sensitivity and secretion. The relationships between alcohol consumption and these parameters were analyzed using logistic regression after adjusting for potential confounders. The 5-year changes in hemoglobin A1c levels were also evaluated. The adjusted odds ratios for elevated homeostasis model assessment of β-cell function values (<40%) in the 0-19.9 g/day, 20.0-39.9 g/day and ≥ 40 g/day alcohol consumption groups were 0.98, 1.46 and 2.68, respectively. Alcohol consumption induced a significant decrease in the insulin secretion level among the ≥40 g/day drinkers, especially in men. However, there was no risk of increased insulin resistance based on the homeostasis model assessment of insulin resistance (<2.5) results. The 5-year risk of elevated hemoglobin A1c levels (≥6.5%) was increased according to increase in alcohol consumption in both men and women. Daily alcohol consumption was associated with reduced insulin secretion and an increased diabetes development risk in Japanese populations.

Identifiants

pubmed: 32227447
doi: 10.1111/jdi.13260
pmc: PMC7477527
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1207-1214

Investigateurs

Kayoko Adachi (K)
Mitsuyo Araki (M)
Kenzo Chimori (K)
Hisashi Daidoh (H)
Katumasa Fushimi (K)
Eiichi Goshima (E)
Hideo Hayashi (H)
Makoto Hayashi (M)
Tatsuyuki Imai (T)
Maho Ishii (M)
Midori Izai (M)
Keita Kamikubo (K)
Yoshinori Kanoh (Y)
Masahisa Kitada (M)
Noriko Kojima (N)
Toshihiro Kojima (T)
Takuji Komaki (T)
Joji Kosaka (J)
Hiroyuki Maekawa (H)
Masanori Murayama (M)
Masafumi Matsuda (M)
Ikuo Matsui (I)
Yoshikazu Morimoto (Y)
Yasuo Morioka (Y)
Hiroshi Murase (H)
Kotaro Nagai (K)
Toshihiko Nagashima (T)
Nobuteru Noda (N)
Nobuyasu Noritake (N)
Kazuhiro Ohmae (K)
Shigehiko Ozeki (S)
Shigeki Sakata (S)
Hiroshi Sarui (H)
Mayumi Sato (M)
Miyuki Sugimoto (M)
Eiji Suzuki (E)
Noriyuki Takeda (N)
Rieko Totani (R)
Takaaki Wada (T)
Yuji Wada (Y)
Michie Yokoyama (M)
Kouji Yoshino (K)

Informations de copyright

© 2020 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd.

Références

Diabetes Care. 2009 Nov;32(11):2123-32
pubmed: 19875607
Diabetes Care. 2013 Jun;36(6):1789-96
pubmed: 23704681
Diabetes Res Clin Pract. 2002 Sep;57(3):191-7
pubmed: 12126769
Diabetes. 2000 Jun;49(6):975-80
pubmed: 10866050
Diabetes Care. 2003 Jul;26(7):1971-8
pubmed: 12832298
Circulation. 1993 Nov;88(5 Pt 1):2190-7
pubmed: 8222114
J Diabetes. 2016 May;8(3):434-41
pubmed: 25991060
Jpn J Clin Oncol. 1999 Jan;29(1):38-44
pubmed: 10073150
Diabetes Care. 2003 Oct;26(10):2785-90
pubmed: 14514580
Curr Diab Rep. 2015 Jun;15(6):602
pubmed: 25944304
Diabetes Care. 2004 Jan;27(1):184-9
pubmed: 14693987
Diabetes Care. 2000 Jan;23(1):18-22
pubmed: 10857962
Diabetes. 2002 Jul;51(7):2170-8
pubmed: 12086947
J Diabetes Investig. 2012 Feb 20;3(1):39-40
pubmed: 24843544
Diabetol Int. 2015 Jul 22;7(2):148-154
pubmed: 30603258
Diabetes Care. 1999 Sep;22(9):1432-7
pubmed: 10480505
J Diabetes Investig. 2010 Oct 19;1(5):212-28
pubmed: 24843435
Diabetes Metab. 2015 Apr;41(2):160-7
pubmed: 25451187
Diabetes Care. 2005 Mar;28(3):719-25
pubmed: 15735217
Diabet Med. 2012 Nov;29(11):1350-7
pubmed: 22957983
Diabetes Care. 2004 Feb;27(2):354-61
pubmed: 14747213
Am J Epidemiol. 1997 May 15;145(10):909-16
pubmed: 9149662
Diabetes. 2001 Oct;50(10):2390-5
pubmed: 11574424
J Med Syst. 1998 Feb;22(1):27-32
pubmed: 9554107
J Epidemiol Community Health. 2002 Jul;56(7):542-8
pubmed: 12080164
Diabetes Care. 2003 Jan;26(1):48-54
pubmed: 12502657
Diabetologia. 2014 Jan;57(1):93-101
pubmed: 24105100
Diabetes Care. 2003 Oct;26(10):2918-22
pubmed: 14514602
Asia Pac J Clin Nutr. 2008;17(4):545-51
pubmed: 19114388
BMJ. 1996 Oct 26;313(7064):1040-4
pubmed: 8898593
Diabet Med. 1998 Jul;15(7):539-53
pubmed: 9686693
Diabet Med. 2005 Mar;22(3):323-31
pubmed: 15717882
Diabetes Care. 2005 Sep;28(9):2230-5
pubmed: 16123495
Diabetes Care. 2010 Jan;33 Suppl 1:S11-61
pubmed: 20042772
Metabolism. 2004 Jul;53(7):831-5
pubmed: 15254872
J Obes. 2014;2014:634587
pubmed: 25140249
J Epidemiol. 2003 Sep;13(5):251-8
pubmed: 14604220
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825

Auteurs

Natsumi Ueda (N)

Laboratory of Drug Informatics, Gifu Pharmaceutical University, Gifu, Japan.

Mayumi Yamamoto (M)

Health Administration Center, and United Graduate School of Drug Discovery and Medical Information Sciences, Gifu University, Gifu, Japan.
Department of Endocrinology and Metabolism, Gifu University Hospital, Gifu, Japan.

Mitsuhiro Nakamura (M)

Laboratory of Drug Informatics, Gifu Pharmaceutical University, Gifu, Japan.

Yumi Motooka (Y)

Laboratory of Drug Informatics, Gifu Pharmaceutical University, Gifu, Japan.

Yoko Nakayama (Y)

Laboratory of Drug Informatics, Gifu Pharmaceutical University, Gifu, Japan.

Yukiko Nonoyama (Y)

Department of Endocrinology and Metabolism, Gifu University Graduate School of Medicine, Gifu, Japan.
Department of Internal Medicine, Midori Hospital, Gifu, Japan.

Shino Oba (S)

Graduate School of Health Sciences, Gumma University, Maebashi, Japan.
Department of Epidemiology and Preventive Medicine, Gifu University Graduate School of Medicine, Gifu, Japan.

Yukio Horikawa (Y)

Department of Endocrinology and Metabolism, Gifu University Graduate School of Medicine, Gifu, Japan.

Chisato Nagata (C)

Department of Epidemiology and Preventive Medicine, Gifu University Graduate School of Medicine, Gifu, Japan.

Daisuke Yabe (D)

Department of Endocrinology and Metabolism, Gifu University Graduate School of Medicine, Gifu, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH